Clinical Trial Update: High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating high-dose ibuprofen for treating patent ductus arteriosus in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: University of Florence | Conditions: Ductus Arteriosus, Patent | Phase 2, Phase 3 | Status: COMPLETED